Login to your account

Lost your password?

Looking for top scoring stocks? Look here


Personal health retailer Medifast (MED) has been a strong outperformer over the last six months, with shares currently trading just shy of their all-time high. The company has a near perfect short-term technical ranking of 100, near perfect long-term technicals and strong fundamental scores, yielding an overall ranking of 94 from InvestorsObserver’s Stock Score Report. The company last reported earnings March 6, with results topping estimates on both the top and bottom line and drove the stock sharply higher. MED currently trades at $89.32, versus its $89.00 average price target, but analysts are likely to lift their targets after the recent earnings beat.

Click here to see a full copy of the report.


Chart courtesy of www.stockcharts.com

Symbols: , , , ,

Michael Fowlkes

Michael Fowlkes is a financial writer who has been with the Fresh Brewed Media family since 2004. Over the course of his tenure with Fresh Brewed Media, he has worn many hats, including portfolio manager, options analyst, and writer. Michael received his undergraduate degree from Virginia Tech in Accounting and got his start in finance working as a stock trader for six years at Chase Investment Counsel in Charlottesville, Va.